Ranjeeta Sinvhal

Long-term safety of risankizumab from 17 clinical trials in patients with moderate-to-severe plaque psoriasis

British Journal of Dermatology · 2022 · 85 citations

Comparative safety and benefit-risk profile of biologics and oral treatment for moderate-to-severe plaque psoriasis: A network meta-analysis of clinical trial data

Systematic review or meta-analysis · Journal of the American Academy of Dermatology · 2021 · 61 citations